HANNAH PICK: Open Payments
NPI 1093112369 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 39 payments from 14 companies in 2025. Trend: 2023 $603 · 2024 $750 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $289 |
| Gilead Sciences, Inc. | 4 | $84 |
| Ardelyx, Inc. | 2 | $68 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Janssen Biotech, Inc. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| PFIZER INC. | 2 | $29 |
| GENZYME CORPORATION | 1 | $29 |
Products named: RINVOQ, IBSRELA, SKYRIZI, DUPIXENT, XIFAXAN, TREMFYA, CREON, IQIRVO.
Industry payments across CO — which companies pay providers there.
